| Severe cutaneous adverse drug reactions WH Chung, CW Wang, RL Dao The Journal of Dermatology 43 (7), 758-766, 2016 | 230 | 2016 |
| Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions CW Wang, LY Yang, CB Chen, HC Ho, SI Hung, CH Yang, CJ Chang, ... The Journal of clinical investigation 128 (3), 985-996, 2018 | 227 | 2018 |
| An updated review of the molecular mechanisms in drug hypersensitivity CB Chen, R Abe, RY Pan, CW Wang, SI Hung, YG Tsai, WH Chung Journal of Immunology Research 2018 (1), 6431694, 2018 | 179 | 2018 |
| Interleukin-15 is associated with severity and mortality in Stevens-Johnson syndrome/toxic epidermal necrolysis SC Su, M Mockenhaupt, P Wolkenstein, A Dunant, S Le Gouvello, ... Journal of Investigative Dermatology 137 (5), 1065-1073, 2017 | 172 | 2017 |
| HLA association with drug‐induced adverse reactions WL Fan, MS Shiao, RCY Hui, SC Su, CW Wang, YC Chang, WH Chung Journal of immunology research 2017 (1), 3186328, 2017 | 161 | 2017 |
| Identification of drug-specific public TCR driving severe cutaneous adverse reactions RY Pan, MT Chu, CW Wang, YS Lee, F Lemonnier, AW Michels, ... Nature communications 10 (1), 3569, 2019 | 102 | 2019 |
| Impact of the HLA-B* 58: 01 allele and renal impairment on allopurinol-induced cutaneous adverse reactions CY Ng, YT Yeh, CW Wang, SI Hung, CH Yang, YC Chang, WC Chang, ... Journal of Investigative Dermatology 136 (7), 1373-1381, 2016 | 97 | 2016 |
| The medication risk of Stevens–Johnson syndrome and toxic epidermal necrolysis in asians: the major drug causality and comparison with the US FDA label YH Wang, CB Chen, W Tassaneeyakul, Y Saito, M Aihara, SE Choon, ... Clinical Pharmacology & Therapeutics 105 (1), 112-120, 2019 | 77 | 2019 |
| The function of HLA-B* 13: 01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions WT Chen, CW Wang, CW Lu, CB Chen, HE Lee, SI Hung, SE Choon, ... Journal of Investigative Dermatology 138 (7), 1546-1554, 2018 | 70 | 2018 |
| A new nucleic acid–based agent inhibits cytotoxic T lymphocyte–mediated immune disorders CW Wang, WH Chung, YF Cheng, NW Ying, K Peck, YT Chen, SI Hung Journal of allergy and clinical immunology 132 (3), 713-722. e11, 2013 | 70 | 2013 |
| HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians SC Su, CB Chen, WC Chang, CW Wang, WL Fan, LY Lu, R Nakamura, ... Clinical Pharmacology & Therapeutics 105 (2), 476-485, 2019 | 66 | 2019 |
| HLA‐B*57:01 confers genetic susceptibility to carbamazepine‐induced SJS/TEN in Europeans M Mockenhaupt, CW Wang, SI Hung, P Sekula, AH Schmidt, RY Pan, ... Allergy 74 (11), 2227-2230, 2019 | 59 | 2019 |
| Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians CW Wang, W Tassaneeyakul, CB Chen, WT Chen, YC Teng, CY Huang, ... Journal of Allergy and Clinical Immunology 147 (4), 1402-1412, 2021 | 56 | 2021 |
| Hypersensitivity and cardiovascular risks related to allopurinol and febuxostat therapy in Asians: a population‐based cohort study and meta‐analysis CH Chen, CB Chen, CJ Chang, YJ Lin, CW Wang, CC Chi, CW Lu, ... Clinical Pharmacology & Therapeutics 106 (2), 391-401, 2019 | 51 | 2019 |
| Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells YS Pu, MW Hsieh, CW Wang, GY Liu, CY Huang, CC Lin, JY Guan, ... Biochemical pharmacology 71 (6), 751-760, 2006 | 48 | 2006 |
| New onset and exacerbations of psoriasis following COVID-19 vaccines: a systematic review PC Wu, IH Huang, CW Wang, CC Tsai, WH Chung, CB Chen American journal of clinical dermatology 23 (6), 775-799, 2022 | 47 | 2022 |
| Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies CC Lin, CB Chen, CW Wang, SI Hung, WH Chung Expert Review of Clinical Immunology 16 (4), 373-387, 2020 | 37 | 2020 |
| Targeted sequencing of circulating tumor DNA to monitor genetic variants and therapeutic response in metastatic colorectal cancer HC Hsu, N Lapke, CW Wang, PY Lin, JF You, CY Yeh, WS Tsai, HY Hung, ... Molecular cancer therapeutics 17 (10), 2238-2247, 2018 | 37 | 2018 |
| HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients P Satapornpong, J Pratoomwun, P Rerknimitr, J Klaewsongkram, ... Frontiers in immunology 12, 661135, 2021 | 36 | 2021 |
| Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions CW Wang, RL Dao, WH Chung Current Opinion in Allergy and Clinical Immunology 16 (4), 339-345, 2016 | 36 | 2016 |
